Dr. Louis C. Rosainz, MD

Dr. Rosainz practices at Baptist Health Surgery Center - Beach Gardens in Miami, Florida.

Dr. Rosainz's NPI, 1073790903, was assigned on January 22, 2008. Dr. Rosainz graduated from St. George's University School of Medicine in 2005. Dr. Rosainz holds Florida license ME109846.

Dr. Rosainz's primary practice is Baptist Health Surgery Center - Beach Gardens, at 9500 S Dadeland Blvd, Miami, FL 33156 in Miami-Dade County. The practice phone is (561) 765-3600.

Dr. Rosainz's primary practice is Baptist Health Surgery Center - Beach Gardens in Miami, Florida. Dr. Rosainz is also affiliated with Jupiter Medical Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Rosainz to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosainz practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Rosainz's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Rosainz is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Rosainz's licenses on file in 2 states: Florida and New York.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Rosainz treats.

CMS data shows 1,321 Medicare services from Dr. Rosainz across 22 procedure codes in 2024, for 681 Medicare patients. Medicare paid $159,775 for them.

CMS counts 681 Medicare patients who saw Dr. Rosainz in 2024. The largest group is 65 to 74, with 373 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rosainz's median patient age at 66, with 44% women.

In 2024, Dr. Rosainz wrote 1,329 Medicare Part D claims for 406 patients. 88% of them were for generic drugs. CMS names the drug for 1,156 of them, across 19 drugs with 11 or more claims each, at $112,658 in total drug cost. In 2023, CMS named 1,040 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Rosainz for performance year 2024, reported as part of a group. Dr. Rosainz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 339 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Rosainz, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Rosainz in 2008. The most frequent topics are Brain, Magnetic Resonance Imaging and Glucose. Dr. Rosainz has published most often in J Child Neurol. Dr. Rosainz's most frequent co-authors are Bernard L. Maria, MD, Kfir Ben-David, MD and Walter E. Drane, MD.

CMS Open Payments shows 420 general payments to Dr. Rosainz from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Abbvie Inc. paid the most, $2,243.

Dmand AI lists 1 award for Dr. Rosainz, most recently CMS Stage 1 EHR in 2013.

Dr. Rosainz graduated from St. George's University School of Medicine in 2005.

Dr. Rosainz is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.